ArticleMolecular therapy. Nucleic acids2021

Systemic delivery of a DUX4-targeting antisense oligonucleotide to treat facioscapulohumeral muscular dystrophy.

Linde F Bouwman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.